Treatment of Surgical Scars With Fractional Photothemolysis Versus Pulse Dye Laser
1 other identifier
interventional
12
1 country
1
Brief Summary
- 1.Evaluate the efficacy of the Fraxel SR laser to improve the cosmetic appearance of surgical scars, both in terms of pigmentary and textural changes.
- 2.Evaluate the efficacy of the V-Beam Pulse Dye laser, a standard non-ablative laser which is utilized for the treatment of the erythematous and telangiectasia component of surgical scars.
- 3.Comparison of the outcome of the half of the surgical scar treated with Fraxel SR laser versus the outcome of the contralateral half of the surgical scar which will be treated with the V-Beam Pulse Dye Laser.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2008
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 23, 2008
CompletedFirst Posted
Study publicly available on registry
May 28, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedApril 10, 2023
April 1, 2023
5 months
May 23, 2008
April 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall cosmetic appearance, relative to adjacent skin and side effects.
6 months
Secondary Outcomes (1)
skin matches surrounding skin, no scar formation visible, skin pigmentation and/or texture of scarred region is markedly different from surrounding skin).
6 months
Study Arms (2)
Fraxel
ACTIVE COMPARATORFraxel laser treatment
PDL
ACTIVE COMPARATORPulsed dye laser treatment
Interventions
Fraxel and pulsed dye laser
Eligibility Criteria
You may qualify if:
- Be at least 18 years old;
- Be otherwise healthy;
- Be treated by Dr. Kouba for a skin cancer surgery or plastic surgery procedure
- Agree to attend up 6 sessions post Mohs surgery (2-4 laser treatment sessions and 2 follow-up visits post-laser)
- Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form;
- Agree to follow and undergo all study-related procedures.
You may not qualify if:
- Patients who do not meet the criteria above and/or who fail to follow their post-operative instructions or make both of their post-operative clinic appointments.
- The control for this study will be the side of the scar treated with the V-Beam Pulse Dye Laser
- We will be speaking to patients at Henry Ford Dermatology regarding participation in our study. We will ensure that all patients understand the voluntary nature of their participation in the study. They will sign informed consent. In addition, we will be asking patients to give us their assessment of which side of their surgical wound had better improvement, the side treated with Fraxel laser versus the side treated with V-Beam Pulse Dye Laser.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Henry Ford Health Systemlead
- American Academy of Cosmetic Surgerycollaborator
Study Sites (1)
Department of Dermatology, Henry Ford Medical Center, 6530 Farmington Rd
West Bloomfield, Michigan, 48322, United States
Related Publications (2)
Alster TS. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg. 1994 Feb;32(2):186-90. doi: 10.1097/00000637-199402000-00015.
PMID: 8192370BACKGROUNDBehroozan DS, Goldberg LH, Dai T, Geronemus RG, Friedman PM. Fractional photothermolysis for the treatment of surgical scars: a case report. J Cosmet Laser Ther. 2006 Apr;8(1):35-8. doi: 10.1080/14764170600607251.
PMID: 16581684BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Kouba, MD, PhD
Department of Dermatology, Henry Ford Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair, Department of Dermatology
Study Record Dates
First Submitted
May 23, 2008
First Posted
May 28, 2008
Study Start
January 1, 2008
Primary Completion
June 1, 2008
Study Completion
July 1, 2008
Last Updated
April 10, 2023
Record last verified: 2023-04